Skip to content

Clinical trials

Lung Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Switzerland Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20032
20042
20052
20061
20072
20081
20091
20106
20111
20123
20131
20144
20155
20169
20176
20182
20192
20202
20214
20222
20235
20243
202510
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55
Recruiting21
Active, not recruiting6
Terminated4
Unknown status4
Not yet recruiting3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Swiss Cancer Institute13
University of Zurich8
Bristol-Myers Squibb6
European Organisation for Research and Treatment of Cancer - EORTC6
Amgen3
Eli Lilly and Company3
Intuitive Surgical3
Kantonsspital Winterthur KSW3
Novartis Pharmaceuticals3
Centre Hospitalier Universitaire Vaudois2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms95
Carcinoma, Non-Small-Cell Lung44
Neoplasms10
Adenocarcinoma of Lung8
Lung Diseases7
Carcinoma6
Breast Neoplasms5
Adenocarcinoma4
Carcinoma, Bronchogenic4
Disease4

Trials

Showing 76 to 95 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.